Lsv Asset Management Harmony Biosciences Holdings, Inc. Transaction History
Lsv Asset Management
- $45.3 Billion
- Q3 2025
A detailed history of Lsv Asset Management transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Lsv Asset Management holds 1,594,893 shares of HRMY stock, worth $52.6 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,594,893
Previous 1,488,502
7.15%
Holding current value
$52.6 Million
Previous $47 Million
6.55%
% of portfolio
0.1%
Previous 0.11%
Shares
8 transactions
Others Institutions Holding HRMY
# of Institutions
295Shares Held
46.2MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$218 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$192 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$168 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.69MShares$55.8 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO1.67MShares$55.1 Million0.02% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.95B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...